nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—ACE Inhibitor Pathway—ACE—type 1 diabetes mellitus	0.071	0.0829	CbGpPWpGaD
Tasosartan—AGTR2—cardiovascular system—type 1 diabetes mellitus	0.044	0.34	CbGeAlD
Tasosartan—AGTR2—kidney—type 1 diabetes mellitus	0.0431	0.333	CbGeAlD
Tasosartan—AGTR2—ACE Inhibitor Pathway—NOS3—type 1 diabetes mellitus	0.0331	0.0386	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—ACE—type 1 diabetes mellitus	0.0231	0.027	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.0159	0.0186	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.0157	0.0184	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.0157	0.0184	CbGpPWpGaD
Tasosartan—AGTR2—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.015	0.0175	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.0134	0.0157	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.0133	0.0155	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.0125	0.0146	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.0116	0.0135	CbGpPWpGaD
Tasosartan—AGTR1—nephron tubule—type 1 diabetes mellitus	0.011	0.0848	CbGeAlD
Tasosartan—AGTR2—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.0109	0.0127	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—PRF1—type 1 diabetes mellitus	0.0109	0.0127	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—NOS3—type 1 diabetes mellitus	0.0108	0.0126	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.0107	0.0125	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.0106	0.0123	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.0106	0.0123	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00993	0.0116	CbGpPWpGaD
Tasosartan—AGTR1—cardiovascular system—type 1 diabetes mellitus	0.00986	0.0762	CbGeAlD
Tasosartan—AGTR1—kidney—type 1 diabetes mellitus	0.00965	0.0745	CbGeAlD
Tasosartan—AGTR1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.00955	0.0112	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00921	0.0107	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00907	0.0106	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00851	0.00993	CbGpPWpGaD
Tasosartan—AGTR1—lymphoid tissue—type 1 diabetes mellitus	0.00829	0.064	CbGeAlD
Tasosartan—AGTR2—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00813	0.00949	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00804	0.00939	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00804	0.00939	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00765	0.00893	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00756	0.00882	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00732	0.00854	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00729	0.00851	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00703	0.00821	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.00694	0.00809	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.00683	0.00797	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.00658	0.00767	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00635	0.00741	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00608	0.0071	CbGpPWpGaD
Tasosartan—Losartan—ACE—type 1 diabetes mellitus	0.00607	0.445	CrCbGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00593	0.00692	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.00579	0.00676	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00557	0.00651	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00555	0.00648	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00551	0.00643	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—INS—type 1 diabetes mellitus	0.00545	0.00635	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.00541	0.00632	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.00521	0.00608	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.00519	0.00606	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.00513	0.00599	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.00513	0.00599	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.00511	0.00597	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.00511	0.00597	CbGpPWpGaD
Tasosartan—Valsartan—ALB—type 1 diabetes mellitus	0.00509	0.373	CrCbGaD
Tasosartan—AGTR1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.00497	0.0058	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00497	0.0058	CbGpPWpGaD
Tasosartan—AGTR1—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00487	0.00569	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.00486	0.00568	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.00475	0.00555	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00472	0.00551	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00463	0.00541	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.0046	0.00536	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.00456	0.00532	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00455	0.0053	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—type 1 diabetes mellitus	0.00454	0.0053	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.00451	0.00526	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00439	0.00512	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00427	0.00499	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00417	0.00487	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00413	0.00482	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00413	0.00482	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.00412	0.0048	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.00392	0.00458	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 signaling events—EGFR—type 1 diabetes mellitus	0.00392	0.00457	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00388	0.00453	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00384	0.00448	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.0038	0.00444	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00378	0.00441	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00359	0.00419	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00359	0.00419	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00356	0.00415	CbGpPWpGaD
Tasosartan—CYP3A4—kidney—type 1 diabetes mellitus	0.00354	0.0274	CbGeAlD
Tasosartan—AGTR2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00348	0.00407	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00348	0.00406	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00344	0.00402	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00344	0.00402	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00326	0.0038	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00325	0.00379	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00324	0.00378	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00321	0.00375	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00315	0.00368	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00314	0.00366	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00309	0.00361	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.00301	0.00351	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00295	0.00345	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00287	0.00335	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00286	0.00334	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00285	0.00332	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00281	0.00328	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—type 1 diabetes mellitus	0.00281	0.00327	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00277	0.00323	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00276	0.00323	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.0027	0.00315	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.00268	0.00313	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.00268	0.00312	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.00267	0.00312	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00265	0.00309	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00263	0.00306	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00262	0.00306	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00262	0.00306	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00262	0.00305	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00255	0.00298	CbGpPWpGaD
Tasosartan—Losartan—ALB—type 1 diabetes mellitus	0.00249	0.182	CrCbGaD
Tasosartan—AGTR2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00247	0.00288	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00246	0.00288	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00245	0.00286	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00244	0.00285	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00244	0.00285	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00239	0.00278	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00238	0.00278	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00238	0.00277	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00237	0.00277	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00229	0.00268	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00229	0.00267	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00207	0.00241	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00206	0.0024	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00203	0.00237	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.002	0.00233	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00198	0.00231	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.00195	0.00227	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00194	0.00226	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00192	0.00225	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00192	0.00225	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00187	0.00218	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00184	0.00215	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00182	0.00212	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00182	0.00212	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00181	0.00211	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00179	0.00209	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SST—type 1 diabetes mellitus	0.00169	0.00197	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00168	0.00196	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00162	0.00189	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00154	0.00179	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00151	0.00176	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.00151	0.00176	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00151	0.00176	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.0015	0.00175	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00148	0.00173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00145	0.00169	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00144	0.00168	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00141	0.00164	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.0014	0.00164	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00139	0.00162	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00136	0.00159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00134	0.00157	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00134	0.00157	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00128	0.00149	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00128	0.00149	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00126	0.00148	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00125	0.00146	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00123	0.00143	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00117	0.00137	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00117	0.00137	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00117	0.00136	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00117	0.00136	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00114	0.00132	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00111	0.00129	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00109	0.00127	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.00107	0.00125	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00107	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00106	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00103	0.0012	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00102	0.00119	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000932	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000928	0.00108	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000917	0.00107	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000915	0.00107	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000896	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000881	0.00103	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000855	0.000998	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000853	0.000995	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—INS—type 1 diabetes mellitus	0.000846	0.000988	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000831	0.00097	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000819	0.000955	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000815	0.000951	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000803	0.000938	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.0008	0.000933	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000794	0.000927	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000794	0.000927	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000779	0.000909	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000777	0.000906	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000775	0.000904	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000756	0.000883	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000747	0.000872	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000742	0.000866	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000705	0.000823	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000671	0.000783	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000661	0.000772	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000652	0.000761	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000631	0.000737	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.00063	0.000735	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000629	0.000734	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000627	0.000732	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000627	0.000732	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000626	0.000731	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000601	0.000701	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000592	0.000691	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000551	0.000643	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000548	0.00064	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000529	0.000618	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000491	0.000573	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000481	0.000562	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000472	0.000551	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000459	0.000535	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000458	0.000534	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000417	0.000487	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000415	0.000485	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.0004	0.000467	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000382	0.000446	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00038	0.000443	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—type 1 diabetes mellitus	0.00037	0.000432	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000361	0.000421	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000355	0.000414	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.00035	0.000408	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000347	0.000405	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000292	0.000341	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000276	0.000322	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000267	0.000311	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000267	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000265	0.00031	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000251	0.000293	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000246	0.000288	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000242	0.000282	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000217	0.000254	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000205	0.00024	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000205	0.000239	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000204	0.000238	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000173	0.000201	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000172	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000157	0.000183	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	0.000145	0.000169	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	0.000136	0.000159	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	0.000136	0.000158	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	0.000133	0.000155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000121	0.000141	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	0.000106	0.000124	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	8.98e-05	0.000105	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	5.96e-05	6.96e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	5.47e-05	6.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	5.23e-05	6.1e-05	CbGpPWpGaD
